You can find the annual or quarterly income statement of Jade Biosciences Ord Shs here for insights into the performance and operational efficiency of Jade Biosciences Ord Shs.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q3

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

Operating expenses

60.15%27.40M

-86.24%3.39M

-70.98%6.40M

-19.93%17.11M

28.66%26.16M

39.57%24.62M

39.20%22.07M

50.99%21.37M

66.48%20.34M

60.08%17.64M

91.73%15.85M

128.26%14.15M

111.55%12.21M

296.37%11.02M

125.72%8.27M

176.42%6.20M

255.32%5.77M

104.71%2.78M

--3.66M

--2.24M

--1.63M

--1.36M

R&D expenses

113.11%22.01M

----

-91.41%1.53M

-38.83%10.33M

32.52%21.25M

48.87%20.08M

45.76%17.81M

56.58%16.88M

91.73%16.03M

85.91%13.49M

142.19%12.22M

215.48%10.78M

93.27%8.36M

230.37%7.25M

53.05%5.05M

73.86%3.42M

194.15%4.33M

82.09%2.20M

--3.30M

--1.97M

--1.47M

--1.21M

Depreciation, depletion, and amortization

-94.50%12.00K

-85.71%4.00K

-71.43%8.00K

772.00%218.00K

27.27%28.00K

33.33%28.00K

40.00%28.00K

25.00%25.00K

29.41%22.00K

90.91%21.00K

150.00%20.00K

566.67%20.00K

750.00%17.00K

450.00%11.00K

700.00%8.00K

--3.00K

--2.00K

--1.00K

--0.00

Operating profit

-60.15%-27.40M

86.24%-3.39M

70.98%-6.40M

19.93%-17.11M

-28.66%-26.16M

-39.57%-24.62M

-39.20%-22.07M

-50.99%-21.37M

-66.48%-20.34M

-60.08%-17.64M

-91.73%-15.85M

-128.26%-14.15M

-111.55%-12.21M

-296.37%-11.02M

-125.72%-8.27M

-176.42%-6.20M

-255.32%-5.77M

-104.71%-2.78M

---3.66M

---2.24M

---1.63M

---1.36M

Net non-operating interest income (expenses)

Non-operating interest income

90.53%2.25M

-39.30%871.00K

-39.85%1.03M

-34.42%1.18M

6.40%1.40M

28.13%1.44M

83.37%1.71M

222.14%1.80M

470.43%1.31M

927.52%1.12M

1882.98%932.00K

3400.00%560.00K

11400.00%230.00K

--109.00K

--47.00K

--16.00K

--2.00K

--0.00

----

Non-operating interest expense

----

--0.00

--37.00K

--38.00K

Special income (expenses)

----

--0.00

---300.00K

----

---64.00K

---540.00K

----

Other non-operating income (expenses)

-180.00%-28.00K

33.33%-2.00K

--0.00

-1100.00%-10.00K

-500.00%-6.00K

-200.00%-3.00K

100.00%0.00

-75.00%1.00K

83.33%-1.00K

---1.00K

-7800.00%-77.00K

--4.00K

-100.00%-6.00K

100.00%0.00

133.33%1.00K

--0.00

---3.00K

97.50%-1.00K

---3.00K

--0.00

---40.00K

Income before tax

-55.05%-25.18M

89.14%-2.52M

73.60%-5.38M

17.00%-16.24M

-30.22%-24.77M

-40.35%-23.19M

-35.74%-20.36M

-43.97%-19.56M

-58.66%-19.02M

-51.42%-16.52M

-82.45%-15.00M

-119.73%-13.59M

-107.64%-11.99M

-292.30%-10.91M

-124.22%-8.22M

-168.05%-6.18M

-162.26%-5.78M

-93.66%-2.78M

---3.67M

---2.31M

---2.20M

---1.44M

Income tax

----

-1.79%55.00K

----

124.00%56.00K

----

733.33%25.00K

----

--3.00K

----

Income after tax

-55.05%-25.18M

89.14%-2.52M

73.40%-5.43M

17.00%-16.24M

-30.22%-24.77M

-40.35%-23.19M

-35.89%-20.41M

-43.97%-19.56M

-58.66%-19.02M

-51.42%-16.52M

-82.68%-15.02M

-119.73%-13.59M

-107.64%-11.99M

-292.30%-10.91M

-124.30%-8.22M

-168.05%-6.18M

-162.26%-5.78M

-93.66%-2.78M

---3.67M

---2.31M

---2.20M

---1.44M

Net income from continuous operations

-55.05%-25.18M

89.14%-2.52M

73.40%-5.43M

17.00%-16.24M

-30.22%-24.77M

-40.35%-23.19M

-35.89%-20.41M

-43.97%-19.56M

-58.66%-19.02M

-51.42%-16.52M

-82.68%-15.02M

-119.73%-13.59M

-107.64%-11.99M

-292.30%-10.91M

-124.30%-8.22M

-168.05%-6.18M

-162.26%-5.78M

-93.66%-2.78M

---3.67M

---2.31M

---2.20M

---1.44M

Net income attributable to controlling interests

-55.05%-25.18M

89.14%-2.52M

73.40%-5.43M

17.00%-16.24M

-30.22%-24.77M

-40.35%-23.19M

-35.89%-20.41M

-43.97%-19.56M

-58.66%-19.02M

-51.42%-16.52M

-82.20%-15.02M

-119.73%-13.59M

-107.31%-11.99M

-290.48%-10.91M

-115.89%-8.24M

-168.05%-6.18M

-162.67%-5.78M

-94.57%-2.79M

---3.82M

---2.31M

---2.20M

---1.44M

Preferred share dividend

----

-100.00%0.00

-85.62%22.00K

----

--9.00K

--13.00K

--153.00K

----

--0.00

----

Net income attributable to common shareholders

-55.05%-25.18M

89.14%-2.52M

73.40%-5.43M

17.00%-16.24M

-30.22%-24.77M

-40.35%-23.19M

-35.89%-20.41M

-43.97%-19.56M

-58.66%-19.02M

-51.42%-16.52M

-82.20%-15.02M

-119.73%-13.59M

-107.31%-11.99M

-290.48%-10.91M

-115.89%-8.24M

-168.05%-6.18M

-162.67%-5.78M

-94.57%-2.79M

---3.82M

---2.31M

---2.20M

---1.44M

Basic earnings per share

96.77%-0.64

89.59%-3.04

74.24%-6.64

20.52%-19.69

-13.97%-30.15

-25.11%-29.20

-20.69%-25.78

-27.38%-24.77

-53.90%-26.46

-49.17%-23.34

-71.06%-21.36

-107.63%-19.45

-96.25%-17.19

-269.65%-15.64

-115.89%-12.49

-168.04%-9.37

-162.67%-8.76

-94.58%-4.23

---5.78

---3.49

---3.34

---2.17

Diluted earnings per share

96.77%-0.64

89.59%-3.04

74.24%-6.64

20.52%-19.69

-13.97%-30.15

-25.11%-29.20

-20.69%-25.78

-27.38%-24.77

-53.90%-26.46

-49.17%-23.34

-71.06%-21.36

-107.63%-19.45

-96.25%-17.19

-269.65%-15.64

-115.89%-12.49

-168.04%-9.37

-162.67%-8.76

-94.58%-4.23

---5.78

---3.49

---3.34

---2.17

Dividend per share

--0.00

Currency unit

USD

Audit opinions

FAQs

What is the income statement?



The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.

KeyAI

